Mobile Menu
Deals & Transactions

Conyers advises Alphamab Oncology in connection with its US$230 million IPO

Conyers acted as special legal counsel in the Cayman Islands and British Virgin Islands to Alphamab Oncology (the Company) on its initial public offering and listing on the main board of the Stock Exchange of Hong Kong.

Alphamab Oncology is an investment holding company primarily engaged in the biopharmaceutical business. The Company is a full-industry chain enterprise specializing in research, development, manufacturing, and the commercialization of innovative tumor immunobiology macromolecular targeted drugs. The Company has bio-innovation drug development technology platform, including protein engineering platform, multi-functional antibody development platform and antibody screening platform. The Company operates its businesses in both domestic and overseas markets.

Partner Vivien Fung and Associate Charissa Ball of Conyers’ Hong Kong office advised Alphamab Oncology on the matter working alongside Sidley Austin.


Charissa Ball

Hong Kong   +852 2842 9550
Mobile  +852 6469 0270


"They are incredibly responsive, and their advice is clear, concise and accessible. They are very commercial and give us succinct answers to questions."
- Chambers Global